Zobrazeno 1 - 10
of 37
pro vyhledávání: '"J. R. B. Green"'
Autor:
M. Deakin, Kar Lau, Damien Durkin, Robert Glass, J. R. B. Green, Terence Wardle, John W. Frost, S Hebbar, Riad Alame
Publikováno v:
Education and Training.
Introduction Nationally there is a drive amongst endoscopists to improve both procedural quality and safety through standardisation and sharing of best practice amongst trainers and trainees. This is perhaps most evident in colonoscopy where a number
Autor:
M. D. Taylor, C. E. Emmas, G. D. Bell, A. T. R. Axon, G. D. Kerr, G. Tildesley, J. R. B. Green, C. M. Bate
Publikováno v:
Alimentary Pharmacology & Therapeutics. 9:513-520
SUMMARY Aims: To compare the efficacy, safety and tolerability of an omeprazole/amoxycillin (OA) dual therapy Helicobacter pylori eradication regimen with an omeprazole/amoxycillin/metronidazole (OAM) triple therapy regimen. Methods: In this double-b
Autor:
Nicholas J. Talley, Ola Junghard, Marc-Andre Bigard, David Armstrong, H. Tunturi-Hihnala, Tore Lind, Thomas L. Venables, Karsten Lauritsen, Bjørn Moum, Joachim Mössner, J. R. B. Green
Publikováno v:
Alimentary Pharmacology & Therapeutics. 20:413-421
Summary Background : Patients with endoscopy-negative reflux disease have reflux symptoms, mainly heartburn, but not mucosal breaks characteristic of erosive oesophagitis. Standard-dose proton pump inhibitors can provide symptom relief in endoscopy-n
Publikováno v:
Alimentary Pharmacology & Therapeutics. 19:435-442
Summary Background : The patient-centred approach is new to the management of ulcerative colitis. To date, it has only been shown to be successful in a short-term study. Aim : To assess the feasibility, safety and efficacy of patient-led dosing using
Autor:
Rolf Carlsson, Thomas L. Venables, Göran Hasselgren, Karna Dev Bardhan, Kevin P J O'Kane, David Armstrong, Mustafa H. Giaffer, Samuel Chen, Nicholas J. Talley, J. R. B. Green
Publikováno v:
European Journal of Gastroenterology & Hepatology. 14:857-863
On-demand therapy may offer an effective approach to the long-term management of gastro-oesophageal reflux disease (GORD) without oesophagitis.To examine the efficacy of the novel proton pump inhibitor esomeprazole as on-demand therapy in endoscopy-n
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:61-68
Background: Sulfasalazine is well established in the treatment of active ulcerative colitis. Intolerance to sulfasalazine, however, is a common problem. Balsalazide has been designed to deliver 5-aminosalicylic acid to the colon without the poor tole
To examine the outcome of endoscopic retrograde cholangiopancreatography (ERCP) in the management of common bile duct (CBD) stones.A retrospective review of 100 consecutive ERCPs performed for CBD stones.100 ERCPs were performed on 84 patients with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6d97a5fb0d950e52eb04c295146a7d
https://europepmc.org/articles/PMC5369731/
https://europepmc.org/articles/PMC5369731/
Publikováno v:
Alimentary Pharmacology & Therapeutics. 15:1331-1341
Background: It may be possible to achieve more effective management of Crohn’s Disease by introducing a flexible dosage regimen sensitive to patients’ needs. Aim: Comparison of the efficacy and tolerability of a fixed vs. flexible budesonide cont
Publikováno v:
European Journal of Gastroenterology & Hepatology. 12:439-443
Objective To determine the prevalence of Helicobacter pylori in patients with inflammatory bowel disease (IBD) and compare this to the prevalence in a control population with non-organic bowel symptoms, and to investigate the effect of sulphasalazine
Autor:
J. P. Crowe, M. D. Taylor, Alan J Lobo, K. J. Schofield, E. T. Swarbrick, C. D. Holdsworth, G. D. Kerr, J. R. B. Green, J. A. Gibson
Publikováno v:
Alimentary Pharmacology & Therapeutics. 12:1207-1216
Background: Despite widespread use of aminosalicylates as maintenance treatment for ulcerative colitis (UC), patients still report troublesome symptoms, often nocturnally. Aim: To compare the efficacy and safety of balsalazide (Colazide) with mesalaz